{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:48:13Z","timestamp":1761155293160},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.brainres.2009.07.034","type":"journal-article","created":{"date-parts":[[2009,7,24]],"date-time":"2009-07-24T08:39:25Z","timestamp":1248424765000},"page":"133-139","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Influence of the Pro12Ala polymorphism of PPAR-\u03b3 on age at onset and sRAGE levels in Alzheimer's disease"],"prefix":"10.1016","volume":"1291","author":[{"given":"Lifen","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keshen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songpo","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongyuan","family":"Piao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2009.07.034_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2009.07.034_bib2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.clinbiochem.2008.05.007","article-title":"The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (receptor for advanced glycation endproducts) and the presence of peripheral arterial disease","volume":"41","author":"Catalano","year":"2008","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.brainres.2009.07.034_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bbadis.2005.03.014","article-title":"RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling","volume":"1741","author":"Chaney","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.brainres.2009.07.034_bib4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1523\/JNEUROSCI.20-02-00558.2000","article-title":"Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists","volume":"20","author":"Combs","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2009.07.034_bib5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1042\/BJ20050560","article-title":"Role of peroxisome proliferator-activated receptor gamma in amyloid precursor protein processing and amyloid beta-mediated cell death","volume":"391","author":"d'Abramo","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.brainres.2009.07.034_bib6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/3099","article-title":"A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity","volume":"20","author":"Deeb","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.brainres.2009.07.034_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbamcr.2005.08.006","article-title":"Evaluation of rage isoforms, ligands, and signaling in the brain","volume":"1746","author":"Ding","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.brainres.2009.07.034_bib8","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1001\/archneur.62.11.1734","article-title":"Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia","volume":"62","author":"Emanuele","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainres.2009.07.034_bib9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0197-4580(00)00147-0","article-title":"Alzheimer's disease: an inflammatory disease?","volume":"21","author":"Fassbender","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2009.07.034_bib10","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.metabol.2007.05.017","article-title":"Association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma2 gene with small dense low-density lipoprotein in the general population","volume":"56","author":"Hamada","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.brainres.2009.07.034_bib11","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ajmg.b.30503","article-title":"Candidate gene association study of insulin signaling genes and Alzheimer's disease: evidence for SOS2, PCK1, and PPARgamma as susceptibility loci","volume":"144B","author":"Hamilton","year":"2007","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.brainres.2009.07.034_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neulet.2008.06.029","article-title":"Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease","volume":"441","author":"Helisalmi","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2009.07.034_bib13","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.bbrc.2008.12.009","article-title":"Splicing factor ASF\/SF2 and transcription factor PPAR-gamma cooperate to directly regulate transcription of uncoupling protein-3","volume":"378","author":"Kim","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2009.07.034_bib14","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1006\/bbrc.1998.9981","article-title":"Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains","volume":"254","author":"Kitamura","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2009.07.034_bib15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1159\/000095857","article-title":"Association analysis of peroxisome proliferator-activated receptor gamma polymorphisms and late onset Alzheimer's disease in the Finnish population","volume":"22","author":"Koivisto","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.brainres.2009.07.034_bib16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0197-4580(01)00296-2","article-title":"Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease","volume":"22","author":"Landreth","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2009.07.034_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.nurt.2008.05.003","article-title":"PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease","volume":"5","author":"Landreth","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.brainres.2009.07.034_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2006.08.024","article-title":"Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism is associated with reduced risk for ischemic stroke with type 2 diabetes","volume":"410","author":"Lee","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2009.07.034_bib19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/clc.4960290706","article-title":"Association between Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma 2 and myocardial infarction in the Chinese Han population","volume":"29","author":"Li","year":"2006","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.brainres.2009.07.034_bib20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/147323000703500407","volume":"35","author":"Matsui","year":"2007","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.brainres.2009.07.034_bib21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2009.07.034_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.brainres.2008.06.124","article-title":"Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease","volume":"1230","author":"Miller","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2009.07.034_bib23","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.molimm.2003.11.027","article-title":"Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cells","volume":"40","author":"Park","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.brainres.2009.07.034_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/sj.tpj.6500397","article-title":"Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease)","volume":"7","author":"Roses","year":"2007","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.brainres.2009.07.034_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1073\/pnas.0503839103","article-title":"Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma","volume":"103","author":"Sastre","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2009.07.034_bib26","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00702-004-0267-z","article-title":"Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients","volume":"112","author":"Sauder","year":"2005","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.brainres.2009.07.034_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.12.078","article-title":"The peroxisome proliferator-activated receptor gamma (PPAR-gamma2) Pro12Ala polymorphism is associated with higher risk for Alzheimer's disease in octogenarians","volume":"1139","author":"Scacchi","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2009.07.034_bib28","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tips.2007.09.004","article-title":"NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development?","volume":"28","author":"Weggen","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.brainres.2009.07.034_bib29","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/0140-6736(91)92823-K","article-title":"Apolipoprotein E genotyping by one-stage PCR","volume":"337","author":"Wenham","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2009.07.034_bib30","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/bbrc.1997.7798","article-title":"Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation","volume":"241","author":"Yen","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2009.07.034_bib31","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1042\/bj20021371","article-title":"Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury","volume":"370","author":"Yonekura","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.brainres.2009.07.034_bib32","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1007\/s00125-006-0437-7","article-title":"Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation","volume":"49","author":"Yoshida","year":"2006","journal-title":"Diabetologia"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899309014395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899309014395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T17:20:31Z","timestamp":1558459231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899309014395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":32,"alternative-id":["S0006899309014395"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2009.07.034","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}